The Cigna Group 🇺🇸
CI • Consumer Cyclical • USA
💡 Institutional Quantitative Investment Thesis
High-quality compounder passing 7/9 fundamental checks. Strong balance sheet with Forward PER compression (10.1x vs 12.7x) and robust Free Cash Flow generation.
📊 Frequently Asked Questions & Related Moat Stocks
1. What is The Cigna Group (CI)'s Economic Moat Score in 2026?
In 2026, The Cigna Group (CI) holds a proprietary MoatPicks Economic Moat Score™ of 74.0/100 (Narrow-to-Wide Moat). This 12-point fundamental audit evaluates CI's 9.1% gross margin, $8.0B free cash flow generation, +6.7% YoY revenue growth, and 2.5x Debt/EBITDA ratio. You can benchmark any stock's competitive durability interactively with our Economic Moat Score™ Checker.
2. Is CI stock undervalued right now based on P/E and PEG ratio?
Yes — CI currently screens as undervalued on a growth-adjusted basis with a Peter Lynch PEG ratio of 0.56x (below the 1.2x GARP threshold) and a Forward P/E of 10.1x. At a share price of $306.95, investors can stress-test CI's fair value using the MoatPicks Economic Moat Score™ Checker and FIRE compounding calculators. Model how compounding CI fits your long-term retirement target in our FIRE Financial Independence Calculator.
3. Which superinvestors and 13F hedge funds own CI stock?
The Cigna Group (CI) is actively monitored across our 25 tracked 13F superinvestor portfolios and institutional quality screens. Institutional capital focuses on CI's 9.1% gross margin, $8.0B free cash flow, and 2.5x Debt/EBITDA balance sheet.